64 related articles for article (PubMed ID: 38740881)
21. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1.
Zhang P; Li S; Lv C; Si J; Xiong Y; Ding L; Ma Y; Yang Y
Theranostics; 2018; 8(21):5890-5902. PubMed ID: 30613269
[TBL] [Abstract][Full Text] [Related]
22. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.
Bekelman JE; Rumble RB; Chen RC; Pisansky TM; Finelli A; Feifer A; Nguyen PL; Loblaw DA; Tagawa ST; Gillessen S; Morgan TM; Liu G; Vapiwala N; Haluschak JJ; Stephenson A; Touijer K; Kungel T; Freedland SJ
J Clin Oncol; 2018 Nov; 36(32):3251-3258. PubMed ID: 30183466
[TBL] [Abstract][Full Text] [Related]
23. Effects of DKK1 overexpression on bone metastasis of SBC-3 cells.
Pang H; Ma N; Shen W; Zhao Q; Wang J; Duan L; Chen W; Zhang N; Zhao Z; Liu L; Zhang H
Oncol Lett; 2018 May; 15(5):6739-6744. PubMed ID: 29731859
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal shock waves trigger tenogenic differentiation of human adipose-derived stem cells.
Rinella L; Marano F; Paletto L; Fraccalvieri M; Annaratone L; Castellano I; Fortunati N; Bargoni A; Berta L; Frairia R; Catalano MG
Connect Tissue Res; 2018 Nov; 59(6):561-573. PubMed ID: 29316809
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin: Its dysregulation in carcinogenesis and clinical implications.
Wong SHM; Fang CM; Chuah LH; Leong CO; Ngai SC
Crit Rev Oncol Hematol; 2018 Jan; 121():11-22. PubMed ID: 29279096
[TBL] [Abstract][Full Text] [Related]
26. A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone.
Wang L; Dehm SM; Hillman DW; Sicotte H; Tan W; Gormley M; Bhargava V; Jimenez R; Xie F; Yin P; Qin S; Quevedo F; Costello BA; Pitot HC; Ho T; Bryce AH; Ye Z; Li Y; Eiken P; Vedell PT; Barman P; McMenomy BP; Atwell TD; Carlson RE; Ellingson M; Eckloff BW; Qin R; Ou F; Hart SN; Huang H; Jen J; Wieben ED; Kalari KR; Weinshilboum RM; Wang L; Kohli M
Ann Oncol; 2018 Feb; 29(2):352-360. PubMed ID: 29069303
[TBL] [Abstract][Full Text] [Related]
27. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1-3p inhibits the proliferation and migration of oral squamous cell carcinoma cells by targeting DKK1.
Wang Z; Wang J; Chen Z; Wang K; Shi L
Biochem Cell Biol; 2018 Jun; 96(3):355-364. PubMed ID: 28763625
[TBL] [Abstract][Full Text] [Related]
29. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.
Kagey MH; He X
Br J Pharmacol; 2017 Dec; 174(24):4637-4650. PubMed ID: 28574171
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
31. TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells.
Janiak M; Paskal W; Rak B; Garbicz F; Jarema R; Sikora K; Włodarski P
APMIS; 2017 Feb; 125(2):101-105. PubMed ID: 28028835
[TBL] [Abstract][Full Text] [Related]
32. Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis.
Kim S; Min A; Lee KH; Yang Y; Kim TY; Lim JM; Park SJ; Nam HJ; Kim JE; Song SH; Han SW; Oh DY; Kim JH; Kim TY; Hangauer D; Lau JY; Im K; Lee DS; Bang YJ; Im SA
Cancer Res Treat; 2017 Jul; 49(3):643-655. PubMed ID: 27737538
[TBL] [Abstract][Full Text] [Related]
33. Wnt signaling in cancer.
Zhan T; Rindtorff N; Boutros M
Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
[TBL] [Abstract][Full Text] [Related]
34. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
35. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model.
Goldstein SD; Trucco M; Bautista Guzman W; Hayashi M; Loeb DM
Oncotarget; 2016 Apr; 7(16):21114-23. PubMed ID: 27049730
[TBL] [Abstract][Full Text] [Related]
36. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.
Watson PA; Arora VK; Sawyers CL
Nat Rev Cancer; 2015 Dec; 15(12):701-11. PubMed ID: 26563462
[TBL] [Abstract][Full Text] [Related]
37. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
Kim SU; Park JH; Kim HS; Lee JM; Lee HG; Kim H; Choi SH; Baek S; Kim BK; Park JY; Kim DY; Ahn SH; Lee JD; Han KH
Yonsei Med J; 2015 Sep; 56(5):1296-306. PubMed ID: 26256972
[TBL] [Abstract][Full Text] [Related]
38. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Sweeney CJ; Chen YH; Carducci M; Liu G; Jarrard DF; Eisenberger M; Wong YN; Hahn N; Kohli M; Cooney MM; Dreicer R; Vogelzang NJ; Picus J; Shevrin D; Hussain M; Garcia JA; DiPaola RS
N Engl J Med; 2015 Aug; 373(8):737-46. PubMed ID: 26244877
[TBL] [Abstract][Full Text] [Related]
39. High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.
Rachner TD; Thiele S; Göbel A; Browne A; Fuessel S; Erdmann K; Wirth MP; Fröhner M; Todenhöfer T; Muders MH; Kieslinger M; Rauner M; Hofbauer LC
BMC Cancer; 2014 Sep; 14():649. PubMed ID: 25182503
[TBL] [Abstract][Full Text] [Related]
40. DKK-1 in prostate cancer diagnosis and follow up.
D'Amelio P; Roato I; Oderda M; Soria F; Zitella A; Ferracini R; Mengozzi G; Gontero P; Isaia GC
BMC Clin Pathol; 2014 Mar; 14(1):11. PubMed ID: 24655661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
